New malaria pill takes first step: is it safe for humans?
NCT ID NCT06854042
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 34 times
Summary
This early-stage study tests a new oral drug called E1018 in 32 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose and are monitored for side effects and drug levels in blood and urine. This study does not aim to treat or prevent malaria, but to gather essential safety data before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PPD Development, LP
RECRUITINGAustin, Texas, 78744, United States
Conditions
Explore the condition pages connected to this study.